Vitaliy Karimov/Shutterstock

Tesla, the electric car company founded and run by Elon Musk, is building mobile molecular printers to assist Germany’s CureVac in manufacturing its experimental COVID-19 vaccine. Musk tweeted the information on Wednesday, July 1.

The “printers” are portable, automated messenger RNA (mRNA) production units, which Musk referred to as “RNA microfactories.”